RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kangmei Pharmaceutical Co Stock

Kangmei Pharmaceutical Co ROCE 2024

Kangmei Pharmaceutical Co ROCE

0.02

Ticker

600518.SS

ISIN

CNE0000017M1

In 2024, Kangmei Pharmaceutical Co's return on capital employed (ROCE) was 0.02, a -116.78% increase from the -0.15 ROCE in the previous year.

Kangmei Pharmaceutical Co Aktienanalyse

What does Kangmei Pharmaceutical Co do?

Kangmei Pharmaceutical Co. Ltd is a Chinese company that was founded in 1997. It is headquartered in the city of Lianyungang in the Jiangsu province and has been listed on the Shanghai Stock Exchange since 2001. With a market capitalization of over 15 billion US dollars, it is one of the leading pharmaceutical companies in the country. The company's business model is based on the development, production, and distribution of pharmaceutical products and medical devices. It is divided into several divisions, including drugs for colds, diabetes, cancer, and other diseases, dietary supplements, contrast agents for X-rays, as well as medical devices such as infusion pumps, blood pressure monitors, and ultrasound machines. Kangmei has focused heavily on the domestic market in recent years and is present in all provinces of China. It operates over 30 subsidiaries throughout the country and has more than 10,000 employees. The company is committed to improving healthcare in China and developing innovative products for the domestic market. One of Kangmei's most well-known drugs is "Ganmaoling Granule," a traditional Chinese medicine for treating colds and flu. It has been in production for over 30 years and is very popular in China. Kangmei also produces various drugs for the treatment of diabetes, including insulin preparations and oral medications. Another important area for Kangmei is the development of cancer drugs. The company specializes in researching and developing innovative therapies for various types of cancer. It has introduced several products to the market that can be used in the treatment of lung cancer, breast cancer, and other tumors. In addition to its pharmaceutical products, Kangmei has also developed a range of dietary supplements, such as "Qingkailing Capsules," which are made from natural ingredients and are intended to strengthen the immune system. These products are very popular in China and also contribute to Kangmei's diversification of its business operations. Kangmei has also specialized in the production of medical devices. It has developed a wide range of products such as infusion pumps, dialysis machines, and ultrasound devices. These devices are in high demand in China and other countries around the world, such as Africa and Latin America. Overall, Kangmei has established a strong presence in the Chinese pharmaceutical and medical market and is well-positioned to benefit from the strong growth of the healthcare sector in China. The company focuses on innovation and invests heavily in research and development of new products. It aims to play a leading role in the Chinese healthcare industry while contributing to the improvement of healthcare services. Kangmei Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Kangmei Pharmaceutical Co's Return on Capital Employed (ROCE)

Kangmei Pharmaceutical Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Kangmei Pharmaceutical Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Kangmei Pharmaceutical Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Kangmei Pharmaceutical Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Kangmei Pharmaceutical Co stock

What is the ROCE (Return on Capital Employed) of Kangmei Pharmaceutical Co this year?

The ROCE of Kangmei Pharmaceutical Co is 0.02 undefined this year.

How has the ROCE (Return on Capital Employed) of Kangmei Pharmaceutical Co developed compared to the previous year?

The ROCE of Kangmei Pharmaceutical Co has increased by -116.78% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Kangmei Pharmaceutical Co?

A high Return on Capital Employed (ROCE) indicates that Kangmei Pharmaceutical Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Kangmei Pharmaceutical Co?

A low ROCE (Return on Capital Employed) can indicate that Kangmei Pharmaceutical Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Kangmei Pharmaceutical Co impact the company?

An increase in the ROCE of Kangmei Pharmaceutical Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Kangmei Pharmaceutical Co affect the company?

A decrease in ROCE of Kangmei Pharmaceutical Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Kangmei Pharmaceutical Co?

Some factors that can affect Kangmei Pharmaceutical Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Kangmei Pharmaceutical Co so important for investors?

The ROCE of Kangmei Pharmaceutical Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Kangmei Pharmaceutical Co take to improve the ROCE?

To improve the ROCE, Kangmei Pharmaceutical Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Kangmei Pharmaceutical Co pay?

Over the past 12 months, Kangmei Pharmaceutical Co paid a dividend of 0.02 CNY . This corresponds to a dividend yield of about 1.28 %. For the coming 12 months, Kangmei Pharmaceutical Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Kangmei Pharmaceutical Co?

The current dividend yield of Kangmei Pharmaceutical Co is 1.28 %.

When does Kangmei Pharmaceutical Co pay dividends?

Kangmei Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of June, July, August, September.

How secure is the dividend of Kangmei Pharmaceutical Co?

Kangmei Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Kangmei Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Kangmei Pharmaceutical Co located?

Kangmei Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kangmei Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kangmei Pharmaceutical Co from 8/28/2019 amounting to 0.024 CNY, you needed to have the stock in your portfolio before the ex-date on 8/28/2019.

When did Kangmei Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 8/28/2019.

What was the dividend of Kangmei Pharmaceutical Co in the year 2023?

In the year 2023, Kangmei Pharmaceutical Co distributed 0 CNY as dividends.

In which currency does Kangmei Pharmaceutical Co pay out the dividend?

The dividends of Kangmei Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kangmei Pharmaceutical Co

Our stock analysis for Kangmei Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kangmei Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.